Mining data on FDA-OK'd drugs leads to potential cancer treatment

How does the anti-malaria drug chloroquine help patients with aggressive breast cancer? It's a question that Dr. Jenny Chang, director of the Methodist Cancer Center in Houston, aims to answer in a new study. "Our team of clinicians and researchers from both the Methodist Cancer Center and The Methodist Hospital Research Institute applied mathematical and bioinformatics models to screen for existing FDA-approved medications that might be effective against cancer stem cells," said Chang in a statement. "We identified chloroquine as [a] potential cancer stem cell killer." Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.